Article
An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac.
Archives of toxicology - 1 Aug 2020
Selvaraj Saravanakumar, Oh Jung-Hwa, Borlak Jürgen
Abstract excerpt
Many drugs have the potential to cause drug-induced liver injury (DILI); however, underlying mechanisms are diverse. The concept of adverse outcome pathways (AOPs) has become instrumental for risk assessment of drug class effects. We report AOPs specific for immune-mediated and drug hypersensitivity/allergic hepatitis by considering genomic, histo- and clinical pathology data of mice and dogs treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
